Market position Specializes in Phase I-IV device and pharmaceutical research with extensive Ph. 1 trial experience and a track record of four FDA audits with no findings, presenting a reliable partner for sponsors seeking rigorous clinical execution.

Mid-market focus Small to mid-sized research site with 11-50 employees and annual revenue in the 1–10 million range, offering a potentially more personalized, flexible, and cost-competitive option for sponsors who need high-touch CRO support.

Expansion potential Strategic location on a 2.6-acre wooded campus off Business I-85 combined with strong Phase I capabilities suggests opportunities to upsell early phase services and site expansion to larger sponsors seeking reliable Phase I throughput.

Tech leverage Adoption of modern tech stack including Power BI, Microsoft 365, Azure, and MySQL enables data-driven trial management, scalable reporting, and integration with sponsor systems, which can be showcased as a competitive advantage in new business pitches.

Quality and stability History of over 450 clinical trials and FDA audit readiness signals reliability and quality, which can be emphasized to de-risk trials for sponsors with stringent regulatory and safety requirements.